Will I relapse if I stop taking Zanubrutinib?

Zanubrutinib (Zanubrutinib) is a drug that treats lymphoma and belongs to a class of drugs called BTK inhibitors. Whether recurrence will occur after stopping the drug mainly depends on the patient's specific situation and the severity of the disease, including the type, grade, and course of the lymphoma. In clinical studies of zanubrutinib, zanubrutinib helped control and reduce the growth of lymphoma cells but did not completely cure the disease. If the lymphoma cells start to grow again after stopping the drug, there is a possibility of recurrence. Each patient's situation is different. Some people may be able to remain in long-term remission after stopping the medication, while others may relapse soon after stopping the medication.